Hepatic steatosisNon-alcoholic fatty liver diseaseAIM To investigate the clinical, biochemical and imaging characteristics of adult cystic fibrosis(CF) patients with hepatic steatosis as compared to normal CF controls.METHODS We performed a retrospective review of adult CF patients in an academic ...
The objective is to estimate the prevalence and risk factors of hepatic steatosis among consecutive patients with stable HIV infection on antiretroviral therapy (ART). Also, the use of transient elastography (TE) as a mean to identify a subgroup at risk for non-alcoholic steatohepatitis (NASH) ...
Prevalence of and risk factors for hepatic steatosis in Northern Italy. BACKGROUND: Although hepatic steatosis is seen with increasing frequency in clinical practice, its prevalence and risk factors are unknown. OBJECTIVE: To i... Bellentani,Stefano - 《Annals of Internal Medicine》 被引量: 4658...
Moreover, BMI, waist, TG, ALT and LSM were independent risk factors of hepatic steatosis, while decreased PLT counts, AST and UAP were independent risk factors of hepatic fibrosis. Body mass parameters, metabolic risk factors and liver function indicators increase the risk of hepatic steatosis ...
Diabetes mellitus (DM), heart failure (HF) and metabolic dysfunction associated steatotic liver disease (MASLD) are overlapping diseases of increasing prevalence. Because there are still high numbers of patients with HF who are undiagnosed and untreated,
et al. Risk factors of hepatic function alterations in hospitalized adult patients treated with short-term parenteral nutrition receiving the same lipid composition at the same dose. Lipids Health Dis 17, 267 (2018). https://doi.org/10.1186/s12944-018-0912-4 Download citation Received18 June ...
Nonalcoholic fatty liver disease (NAFLD) is a severe form of chronic liver disease[1,2]and represents a spectrum of conditions ranging from simple hepatic steatosis to nonalcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma[3]. The prevalence of NAFLD is approximately 29.81% in China[...
The nonalcoholic steatohepatitis is a critical link in the chain of metabolic fatty liver disorders that spans steatosis to cryptogenic cirrhosis. It is the hepatic manifestation of the insulin resistance (or metabolic) syndrome, and provides a clue to understanding fibrotic progression of other ...
Hepatic involvement of MetS is commonly observed as hepatic steatosis in nonalcoholic fatty liver disease (NAFLD); pathological fat accumulation associated with chronic inflammation in the liver results in detrimental consequences, including impairment of glucose and lipid metabolism and an increase in card...
FLI ≥ 60: hepatic steatosis [13]. To assess to which extent FLI could be associated to overall risk independent of other risk factors we have calculated the Steno Type 1 Risk Engine (ST1-RE) [14]. The ST1-RE is a risk model for composite CV outcome (risk of first fatal or ...